๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Overall survival analysis of a randomized phase III trial comparing nab-paclitaxel with solvent-based paclitaxel in patients with metastatic breast cancer previously treated with anthracycline

โœ Scribed by N. Davidson; S. Tjulandin; J. O'Shaughnessy; P. Bhar; W. Gradishar


Book ID
119598376
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
59 KB
Volume
6
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A phase 2 clinical trial of nab-paclitax
โœ Evan M. Hersh; Steven J. O'Day; Antoni Ribas; Wolfram E. Samlowski; Michael S. G ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 234 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND: __nab__โ€Paclitaxel (ABIโ€007, Abraxane), a 130โ€nM, albuminโ€bound (__nab__) particle form of Cremophorโ€free paclitaxel, is approved for metastatic breast cancer. In the current study, the efficacy and safety of __nab__โ€paclitaxel were evaluated in previously treated and ch